drugset / Trial / NCT01207908
Safety and Efficacy Study of IGF-1 in Duchenne Muscular Dystrophy
Phase 1/2
Completed
44 enrolled
Children's Hospital Medical Center, Cincinnati
Charley's Fund · collabIpsen · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to determine whether IGF-1 therapy improves or preserves muscle function in Duchenne Muscular Dystrophy (DMD).
Timeline
- Start
- 2010-11
- Primary completion
- 2012-10
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | mecasermin | Protein / enzyme biologic | — | Subcutaneous |